Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: IPSEN Bioscience Inc.
July 16, 2025
IPSEN Bioscience Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of primary sclerosing cholangitis
Disease Area:
Rare Diseases
Source
Scroll to Top
